Syndrome hémolytique et urémique de l’adulte jeune par trouble du métabolisme de la cobalamine : à propos d’un cas

Kaaniche, Fatma Medhioub; Chaari, Anis; Bacouch, Najeh; Bahloul, Mabrouk; Bouaziz, Mounir

doi:10.1016/j.lpm.2015.10.014

Cited by 3 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[ 3 , 6 , 7 ] So far, only a few cases of HUS have been triggered by a metabolic disease, such as diabetes mellitus [ 8 , 9 ] and metabolic disorder of cobalamin. [ 10 , 11 ] Recently, Adrovic et al described a case of a 6-year-old girl with CblC disorder, who was found to have a homozygous mutation in exon 4 of MMACHC, c. 484G >T. [ 11 ] Although the serum level of VitB12 was normal in the patient, the bone marrow showed an obvious degeneration, so we highly suspected that it was caused by metabolic abnormalities of cobalamin.…”

Section: Discussionmentioning

confidence: 99%

Atypical hemolytic uremic syndrome induced by CblC subtype of methylmalonic academia

et al. 2017

View full text Add to dashboard Cite

Rationale:Methylmalonic acidemia (MMA) is a common organic acidemia, mainly due to methylmalonyl-CoA mutase (MCM) or its coenzyme cobalamin (VitB12) metabolic disorders. Cobalamin C (CblC) type is the most frequent inborn error of cobalamin metabolism; it can develop symptoms in childhood and often combine multisystem damage, which leads to methylmalonic acid, propionic acid, methyl citrate, and other metabolites abnormal accumulation, causing nerve, liver, kidney, bone marrow, and other organ damage.Patient concerns:A 4-year-old girl presented with paleness, fatigue, severe normochromic anemia, and acute kidney injury.Diagnosis:Based on severe normochromic anemia and acute kidney injury, renal biopsy showed membranous proliferative glomerular lesions and thrombotic microvascular disease, supporting the diagnosis of aHUS. Although the serum vitamin B12 was normal, further investigation found the concentration of urinary methylmalonic acid and serum homocysteine increased obviously, genetic analysis revealed a heterozygous MMACHC mutation (exonl: c. 80A >G, c. 609G >A). The final diagnosis was aHUS induced by inherited methylmalonic acidemia (MMACHC heterozygous mutation exonl: c. 80A >G, c. 609G >A).Interventions:The patient was treated with a 1mg vitamin B12 intramuscular injection daily for 4 days after which the dose was then adjusted to a 1mg intramuscular injection twice a week. At the same time, the girl was given levocarnitine, betaine, folic acid, along with supportive treatment.Outcomes:After treated by vitamin B12 for 10 days, the patient condition significantly improved, Follow-up results showed complete recovery of hemoglobin and renal function.Lessons:Although the majority of MMA onset from neurological damage, our case illustrates that partial CblC-type MMA can onset with severe metabolic aHUS. On the basis of chronic thrombotic microangiopathy (TMA)-induced renal damage, it can be complicated by acute hemolytic lesions. MMA should be considered in those patients with unclear microangiopathic hemolytic anemia accompany significant megaloblastic degeneration in bone marrow. We should pay attention to the causes and adopt a reasonable treatment strategy.

show abstract